CEACAM5 and neoplasm: Although CEA and CA19-9, the tumor markers that are most widely used, were found to have a poor diagnostic ability for the screening of GI and whole-body cancers in this study, several other potential markers, including hematopoietic growth factors, enzymes, circulating tumor cells, and genetic markers, are being developed or evaluated29.